Ribavirin in the treatment of hepatitis C.

@article{Abonyi2005RibavirinIT,
  title={Ribavirin in the treatment of hepatitis C.},
  author={Margit E Abonyi and P L Lakatos},
  journal={Anticancer research},
  year={2005},
  volume={25 2B},
  pages={1315-20}
}
The hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide, with approximately 170-200 million people infected. The HCV virus is transmitted by blood and blood products and such transmission occurs primarily through drug use by injection, sex with an infected partner and occupational exposure. The severity of the disease varies widely from mild chronic hepatitis to cirrhosis and hepatocellular carcinoma (HCC). Nowadays, the reference treatment is combination therapy of… CONTINUE READING

4 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
RibavirinContraindicated with diseaseAnemia
Heterozygosityfor the C282Y mutation in HFE contributes to iron accumulation and fibrosis progression in chronic hepatitis C. Ribavirin could cause dose - dependent reversible haemolytic anaemia , which can be managed with dose reductions or with administration of epoetin alpha at 40,000 IU once weekly without sacrificing the optimal dosing of ribavarin .
Nowadays , the reference treatment is combination therapy of pegylated interferon and ribavirin , which is an inosine monophosphate dehydrogenase inhibitor and immunomodulator .
Nowadays , the reference treatment is combination therapy of pegylated interferon and ribavirin , which is an inosine monophosphate dehydrogenase inhibitor and immunomodulator .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
Ribavirin in the treatment of hepatitis C. The hepatitis C virus ( HCV ) is a major cause of chronic liver disease worldwide , with approximately 170 - 200 million people infected .
All Topics